Top Approvals Stories


Comment & Analysis »

GlobalData Healthcare

Promising cancer drug for Cachexia rejected by CHMP

Cancer cachexia is a wasting condition that is characterized by systemic inflammation, negative protein and energy balance, and an involuntary loss of lean body...

Promising cancer drug for Cachexia rejected by CHMP
GlobalData Healthcare

Green light for TissueGene as Invossa gains approval in Korea

Green light for TissueGene as Invossa gains approval in Korea
GlobalData Healthcare

Acne treatment: bacteria to the rescue?

Acne treatment: bacteria to the rescue?
GlobalData Healthcare

pSivida: positioning Durasert as the longest-acting Ocular steroid implant

pSivida: positioning Durasert as the longest-acting Ocular steroid implant
GlobalData Healthcare

Merck’s Oral Multiple Sclerosis Therapy Cladribine Finally Gains Support From EU Panel

Merck’s Oral Multiple Sclerosis Therapy Cladribine Finally Gains Support From EU Panel

Company Releases »

Pharmaceutical Contract Development, Manufacturing, Packaging and Distribution

Kemwell
Pharmaceutical Contract Development, Manufacturing, Packaging and Distribution

Paediatric Clinical Trials 2016

SMI
Paediatric Clinical Trials 2016

Bioneer Biomarker Services

Bioneer Bioneer Biomarker Services

Disease Models, Biomarkers, Recombinant Proteins and Formulation Services

Bioneer
Disease Models, Biomarkers, Recombinant Proteins and Formulation Services

Kemwell: Keeping You Competitive

Kemwell Kemwell: Keeping You Competitive

Approvals Insights »

Companies »